State College, PA, United States of America

Jennifer E Ray


Average Co-Inventor Count = 9.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jennifer E. Ray

Introduction

Jennifer E. Ray, an accomplished inventor based in State College, PA, has made significant contributions to the field of biotechnology. With a total of four patents to her name, her work centers around the development of polypeptides and methods that are crucial in the fight against bacterial infections.

Latest Patents

Among her latest patents, Jennifer has developed innovations related to tktA from Streptococcus pneumoniae. This invention provides tktA polypeptides and the polynucleotides that encode these polypeptides, as well as methods for producing them through recombinant techniques. Her work also outlines methods for utilizing tktA polypeptides and polynucleotides to screen for antibacterial compounds, which could potentially lead to new treatments. Another notable patent focuses on gcp polypeptides and their encoding polynucleotides, also detailing the recombinant production methods and applications in antibacterial compound screening.

Career Highlights

Jennifer E. Ray is currently affiliated with SmithKline Beecham Corporation, where she leverages her expertise to drive innovation in the biotechnology sector. Her focus on antibacterial compounds positions her work at the forefront of developing new therapeutic solutions.

Collaborations

Throughout her career, Jennifer has collaborated with esteemed colleagues, including David John Holmes and Karen Anne Ingraham. These partnerships have allowed for a fruitful exchange of ideas, contributing to advancements in their respective research projects.

Conclusion

Jennifer E. Ray exemplifies the spirit of innovation within the field of biotechnology. Her notable patents and collaborative efforts continue to pave the way for breakthroughs in combating bacterial infections, highlighting her as a pivotal figure in her industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…